Legal Accountability: Lawsuits, Verdicts, Manufacturer Conduct, and Barriers Faced by Artificial Stone Workers

As artificial stone silicosis cases rise across the United States, legal accountability has become one of the most critical areas of focus. Workers suffering from accelerated and acute silicosis—caused by exposure to crystalline silica artificial stone containing at least 90% silica in nano‑sized particles and approximately 10% toxic metals, resins and VOCs—have sought justice through the courts, revealing an alarming pattern of manufacturer conduct and legislative proposals that threaten their rights.

This post examines the emerging legal landscape, including landmark verdicts, evidence presented at trial, the role of foreign slab manufacturers, and federal legislative efforts such as HR 5437 that would dramatically limit workers’ ability to pursue claims.

The Basis for Legal Accountability: What the Evidence Shows

Product liability and negligence claims filed on behalf of workers across California and the United States rest on extensive medical, scientific, and regulatory evidence that:

• Artificial stone produces nano‑sized respirable crystalline silica particles that penetrate deep into the lungs
• Engineering controls and PPE fail to reduce exposure to acceptable levels
• Crystalline silica artificial stone dust causes accelerated and acute silicosis, lung cancer, chronic kidney disease, autoimmune disorders, and other serious illnesses
• Traditional fabrication methods that were historically safe for natural stone became hazardous only after artificial stone entered the market

Numerous peer‑reviewed scientific studies, NIOSH analyses, and public health surveillance data confirm that crystalline silica artificial stone generates dangerously high levels of respirable crystalline silica even under controlled conditions.

Furthermore, stone countertop fabrication had zero documented silicosis cases worldwide before the introduction of artificial stone slabs to the countertop market. Once crystalline silica artificial stone displaced natural stone, silicosis rates rapidly increased from zero to epidemic levels.

These findings form the scientific and legal foundation for claims against (mostly foreign) artificial stone slab manufacturers and distributors.

Landmark Verdicts: How Juries Have Responded

One of the most significant legal milestones in artificial stone litigation occurred when a jury in the first plaintiff’s trial awarded over $52 million to fabricator Gustavo Reyes González.

The verdict reflected several compelling factors presented at trial:

1. The Severity of Accelerated Silicosis

Evidence showed that the worker developed advanced, debilitating lung disease requiring continuous oxygen and facing the prospect of lung transplantation—a temporary, high‑risk intervention with an average lifespan of only several years post‑transplant.

2. The Uniqueness of Artificial Stone Dust

Jurors heard detailed testimony about crystalline silica artificial stone’s ultra‑high silica content, nano‑sized particulate structure, and toxic additives. These features make the dust fundamentally different—and significantly more dangerous—than natural stone dust.

3. The Failure of Safety Measures

Scientific evidence demonstrated that engineering controls, wet cutting, respirators, and high‑end dust suppression equipment fail to protect workers from exposure. Even the most sophisticated shops have experienced high silicosis rates.

4. Manufacturer Knowledge and Conduct

Evidence presented in litigation describes how manufacturers produced slabs with extraordinarily high silica content and nano‑sized dust characteristics, despite the existence of safer alternatives such as recycled glass slabs and natural stone.

Additionally, testimony and regulatory findings indicate that slab manufacturers and affiliated trade groups have repeatedly opposed measures aimed at addressing the public health crisis. In some instances, they have promoted the inaccurate claim that artificial stone can be safely fabricated using controls designed for natural stone.

Manufacturer Conduct: What Testimony and Evidence Reveal

Significant evidence presented in hearings and litigation provides additional context regarding manufacturer behavior.

1. Foreign Slab Manufacturers Dominate the Market

Ninety‑nine percent of artificial stone slabs are imported from companies in 17 countries. These manufacturers generate approximately $25 billion annually from sales to the U.S. market.

Trade groups aligned with these manufacturers—including ISFA—have:

• Opposed restrictions on artificial stone
• Promoted “safe fabrication” methods that scientific authorities have found ineffective
• Attempted to influence state and federal legislation
• Provided testimony contradictory to published scientific evidence

2. Interference with Regulatory Processes

At the January 2026 Cal OSHA Standards Board hearing:

• WOEMA, representing 600+ occupational medicine physicians, was not allowed a full presentation of its petition
• ISFA and other foreign manufacturer‑aligned groups were given extended time to speak
• Cal OSHA’s own medical staff confirmed crystalline silica artificial stone cannot be safely fabricated, yet their scientific evidence was sidelined in favor of industry statements

3. Availability of Safer Alternatives

Evidence shows that safer alternatives—such as recycled glass slabs and natural stone—are already widely available and require no new machinery or fabrication processes. When Australia banned artificial stone, manufacturers transitioned to safer materials without job losses or industry disruption.

These facts raise serious concerns about manufacturer decision‑making and the continued promotion of a product associated with high disease rates.

Legal Obstacles Workers Face: HR 5437 and Industry‑Backed Proposals

While lawsuits have provided a pathway for workers to seek accountability, industry‑backed legislation threatens to eliminate that avenue.

HR 5437: Shielding Manufacturers from Liability

The proposed federal bill HR 5437 would:

• Prohibit civil lawsuits against mostly-foreign artificial stone manufacturers and distributors
• Block claims even in cases involving severe or fatal silicosis
• Remove the primary mechanism that currently encourages product safety improvements

Occupational health authorities have strongly opposed the bill. Dr. David Michaels testified that eliminating lawsuits removes a critical tool that has historically forced companies to correct dangerous practices.

Why HR 5437 Threatens Worker Rights

Workers with accelerated or acute silicosis face:

• Extreme medical costs
• Loss of income
• Reduced life expectancy
• The need for oxygen or lung transplantation
• Emotional and financial strain on their families

Without the ability to pursue legal action, workers harmed by artificial stone fabrication are left without a viable path for compensation or accountability.

Conclusion

The legal landscape surrounding artificial stone silicosis reveals a troubling pattern: severe worker harm, strong scientific evidence showing crystalline silica artificial stone’s inherent dangers, and a coordinated effort by foreign manufacturers and aligned groups to avoid accountability.

Legal outcomes—including multimillion‑dollar verdicts and settlements—reflect public recognition of the gravity of the crisis and the devastating effects of accelerated silicosis. At the same time, legislative initiatives such as HR 5437 threaten to remove essential legal protections for workers.

The evidence demonstrates that crystalline silica artificial stone’s unique toxicity—not worker behavior, not shop practices, not employer negligence—is the driving force behind the modern silicosis epidemic. As workers across the nation continue to face life‑altering and ultimately fatal disease, legal accountability remains a critical tool for addressing the profound harm caused by artificial stone.